Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thrombocytosis × siltuximab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1 Classical hematology 1

Conditions

Thrombocytosis 1 Thrombocytopenia 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Kidney Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Renal Cell 1 Anemia 1

Interventions

siltuximab 1 ruxolitinib 1 pelcitoclax 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Northwestern University

Phase EARLY_PHASE1 Withdrawn

Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡